| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Single-Cell Analysis | 46 | 2024 | 2277 | 3.930 |
Why?
|
| Sequence Analysis, RNA | 27 | 2023 | 1979 | 2.240 |
Why?
|
| High-Throughput Nucleotide Sequencing | 12 | 2023 | 3614 | 1.490 |
Why?
|
| Respiratory Mucosa | 4 | 2021 | 453 | 1.200 |
Why?
|
| Gene Expression Profiling | 26 | 2023 | 9320 | 1.140 |
Why?
|
| Tumor Microenvironment | 9 | 2022 | 3695 | 1.100 |
Why?
|
| Immunity | 5 | 2024 | 993 | 1.020 |
Why?
|
| Nanowires | 5 | 2013 | 32 | 1.020 |
Why?
|
| Nasal Polyps | 5 | 2021 | 392 | 0.960 |
Why?
|
| Paneth Cells | 2 | 2022 | 98 | 0.940 |
Why?
|
| B-Lymphocytes | 13 | 2024 | 4673 | 0.900 |
Why?
|
| Dendritic Cells | 12 | 2022 | 2713 | 0.900 |
Why?
|
| Cell Tracking | 2 | 2022 | 139 | 0.890 |
Why?
|
| Mycobacterium tuberculosis | 8 | 2024 | 1860 | 0.880 |
Why?
|
| Organoids | 5 | 2022 | 705 | 0.820 |
Why?
|
| Silicon | 3 | 2013 | 143 | 0.770 |
Why?
|
| Meningeal Carcinomatosis | 1 | 2021 | 62 | 0.760 |
Why?
|
| Microfluidic Analytical Techniques | 6 | 2019 | 829 | 0.750 |
Why?
|
| RNA, Small Cytoplasmic | 1 | 2020 | 19 | 0.750 |
Why?
|
| Goblet Cells | 2 | 2020 | 295 | 0.690 |
Why?
|
| CD8-Positive T-Lymphocytes | 17 | 2024 | 4516 | 0.680 |
Why?
|
| RNA, Messenger | 11 | 2022 | 12767 | 0.670 |
Why?
|
| Epithelial Cells | 7 | 2024 | 3667 | 0.660 |
Why?
|
| T-Lymphocytes | 9 | 2023 | 10018 | 0.650 |
Why?
|
| Coloring Agents | 1 | 2021 | 554 | 0.650 |
Why?
|
| DNA Barcoding, Taxonomic | 2 | 2017 | 133 | 0.650 |
Why?
|
| Cell Communication | 4 | 2023 | 1625 | 0.650 |
Why?
|
| Research Subjects | 1 | 2020 | 245 | 0.630 |
Why?
|
| Tuberculosis | 6 | 2024 | 1957 | 0.630 |
Why?
|
| Pulmonary Fibrosis | 1 | 2022 | 529 | 0.610 |
Why?
|
| HIV Infections | 16 | 2023 | 16936 | 0.600 |
Why?
|
| Host-Pathogen Interactions | 4 | 2021 | 1444 | 0.600 |
Why?
|
| Th2 Cells | 2 | 2019 | 1028 | 0.590 |
Why?
|
| Carcinoma, Pancreatic Ductal | 4 | 2023 | 1672 | 0.580 |
Why?
|
| Immunity, Cellular | 2 | 2020 | 1550 | 0.580 |
Why?
|
| Inflammation | 6 | 2021 | 10633 | 0.570 |
Why?
|
| Germinal Center | 4 | 2021 | 379 | 0.570 |
Why?
|
| Stem Cells | 5 | 2022 | 3513 | 0.550 |
Why?
|
| Immunologic Memory | 5 | 2022 | 1330 | 0.540 |
Why?
|
| Macrophages | 13 | 2023 | 5664 | 0.510 |
Why?
|
| Epithelium | 1 | 2020 | 1609 | 0.500 |
Why?
|
| Animals | 73 | 2024 | 166558 | 0.490 |
Why?
|
| Biological Evolution | 1 | 2020 | 1056 | 0.490 |
Why?
|
| Mice | 54 | 2023 | 80251 | 0.480 |
Why?
|
| Ovarian Follicle | 4 | 2023 | 242 | 0.460 |
Why?
|
| HIV | 1 | 2020 | 1584 | 0.440 |
Why?
|
| Paracrine Communication | 1 | 2014 | 276 | 0.420 |
Why?
|
| Vitrification | 2 | 2023 | 55 | 0.410 |
Why?
|
| Meningeal Neoplasms | 1 | 2021 | 1227 | 0.410 |
Why?
|
| RNA | 5 | 2023 | 2696 | 0.400 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2015 | 2519 | 0.400 |
Why?
|
| Skin | 4 | 2021 | 4389 | 0.390 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 3 | 2022 | 790 | 0.390 |
Why?
|
| Atlases as Topic | 4 | 2021 | 239 | 0.380 |
Why?
|
| Adaptive Immunity | 3 | 2020 | 722 | 0.380 |
Why?
|
| Reverse Transcription | 2 | 2023 | 47 | 0.380 |
Why?
|
| Immunity, Innate | 6 | 2020 | 3025 | 0.380 |
Why?
|
| Cell Differentiation | 12 | 2022 | 11384 | 0.370 |
Why?
|
| Pancreatic Neoplasms | 4 | 2023 | 5260 | 0.370 |
Why?
|
| Gene Expression Regulation | 9 | 2022 | 11865 | 0.360 |
Why?
|
| Immune System | 2 | 2018 | 801 | 0.340 |
Why?
|
| Ebolavirus | 2 | 2023 | 252 | 0.340 |
Why?
|
| Nasal Mucosa | 3 | 2024 | 410 | 0.340 |
Why?
|
| Interferon Type I | 3 | 2024 | 545 | 0.340 |
Why?
|
| Hypersensitivity | 1 | 2018 | 1138 | 0.330 |
Why?
|
| Transcription, Genetic | 9 | 2021 | 7572 | 0.330 |
Why?
|
| Immunophenotyping | 4 | 2021 | 1854 | 0.330 |
Why?
|
| HEK293 Cells | 6 | 2021 | 4182 | 0.330 |
Why?
|
| HIV-1 | 7 | 2020 | 6872 | 0.320 |
Why?
|
| Bystander Effect | 3 | 2024 | 88 | 0.320 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 3 | 2020 | 975 | 0.320 |
Why?
|
| Humans | 111 | 2024 | 746630 | 0.320 |
Why?
|
| Macrophages, Alveolar | 2 | 2022 | 408 | 0.320 |
Why?
|
| RNA Splicing | 1 | 2013 | 904 | 0.310 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2024 | 549 | 0.310 |
Why?
|
| Molecular Imaging | 1 | 2015 | 824 | 0.310 |
Why?
|
| CD4-Positive T-Lymphocytes | 7 | 2023 | 4297 | 0.300 |
Why?
|
| Intestines | 4 | 2022 | 1894 | 0.300 |
Why?
|
| Interferon-gamma | 5 | 2021 | 3143 | 0.300 |
Why?
|
| Neoplastic Cells, Circulating | 3 | 2021 | 939 | 0.290 |
Why?
|
| Hemorrhagic Fever, Ebola | 2 | 2023 | 414 | 0.290 |
Why?
|
| Simian immunodeficiency virus | 2 | 2024 | 818 | 0.290 |
Why?
|
| Liver | 6 | 2023 | 7382 | 0.280 |
Why?
|
| Histocompatibility Antigens Class I | 3 | 2022 | 1338 | 0.280 |
Why?
|
| Killer Cells, Natural | 4 | 2020 | 2170 | 0.280 |
Why?
|
| Monocytes | 6 | 2023 | 2545 | 0.280 |
Why?
|
| Proteome | 1 | 2016 | 1813 | 0.280 |
Why?
|
| Lymphocytes | 3 | 2020 | 2589 | 0.280 |
Why?
|
| Sinusitis | 3 | 2021 | 977 | 0.270 |
Why?
|
| Brain Neoplasms | 4 | 2021 | 8856 | 0.270 |
Why?
|
| Lymphoid Tissue | 2 | 2020 | 449 | 0.270 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 3452 | 0.270 |
Why?
|
| Viral Load | 5 | 2021 | 3297 | 0.260 |
Why?
|
| Cells, Cultured | 14 | 2023 | 18905 | 0.260 |
Why?
|
| Genomics | 10 | 2024 | 5695 | 0.260 |
Why?
|
| Granuloma | 3 | 2023 | 324 | 0.260 |
Why?
|
| Myeloid Cells | 2 | 2021 | 801 | 0.250 |
Why?
|
| Macaca mulatta | 8 | 2024 | 2328 | 0.250 |
Why?
|
| Biomedical Research | 1 | 2020 | 3328 | 0.250 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2014 | 1626 | 0.240 |
Why?
|
| Lentivirus Infections | 1 | 2024 | 11 | 0.240 |
Why?
|
| Interleukin-4 | 2 | 2018 | 1105 | 0.240 |
Why?
|
| Hemorrhagic Fevers, Viral | 1 | 2023 | 23 | 0.230 |
Why?
|
| Interleukin-5 Receptor alpha Subunit | 2 | 2021 | 18 | 0.230 |
Why?
|
| Gene Library | 2 | 2019 | 1064 | 0.230 |
Why?
|
| Acute Disease | 5 | 2021 | 7124 | 0.230 |
Why?
|
| Cytokines | 5 | 2021 | 7236 | 0.220 |
Why?
|
| Multifactorial Inheritance | 2 | 2023 | 1297 | 0.220 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2020 | 1824 | 0.220 |
Why?
|
| Macaca fascicularis | 2 | 2022 | 904 | 0.220 |
Why?
|
| Anovulation | 1 | 2023 | 55 | 0.220 |
Why?
|
| Cell Line, Tumor | 13 | 2021 | 16667 | 0.220 |
Why?
|
| Gene Regulatory Networks | 3 | 2020 | 1699 | 0.210 |
Why?
|
| Lung | 7 | 2024 | 9918 | 0.210 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2022 | 2511 | 0.210 |
Why?
|
| Immune Evasion | 2 | 2023 | 361 | 0.210 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2021 | 3012 | 0.210 |
Why?
|
| Microfluidics | 2 | 2019 | 662 | 0.210 |
Why?
|
| Interleukin-17 | 3 | 2024 | 894 | 0.210 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2023 | 126 | 0.210 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2023 | 124 | 0.200 |
Why?
|
| Histocompatibility Antigens Class II | 4 | 2021 | 1420 | 0.200 |
Why?
|
| Rhinitis | 2 | 2021 | 738 | 0.200 |
Why?
|
| Liver Regeneration | 2 | 2020 | 213 | 0.200 |
Why?
|
| Leprosy, Tuberculoid | 1 | 2021 | 15 | 0.200 |
Why?
|
| T-Lymphocytes, Cytotoxic | 4 | 2024 | 1801 | 0.200 |
Why?
|
| Enterocytes | 2 | 2020 | 219 | 0.200 |
Why?
|
| Contraceptive Agents | 1 | 2023 | 142 | 0.200 |
Why?
|
| Leprosy, Lepromatous | 1 | 2021 | 23 | 0.200 |
Why?
|
| HIV Antibodies | 2 | 2020 | 1289 | 0.190 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2021 | 41 | 0.190 |
Why?
|
| Cyclin D3 | 1 | 2021 | 54 | 0.190 |
Why?
|
| Mycobacterium leprae | 1 | 2021 | 96 | 0.190 |
Why?
|
| Fluoresceins | 1 | 2021 | 234 | 0.190 |
Why?
|
| Hepatocytes | 4 | 2022 | 1209 | 0.190 |
Why?
|
| Cell Cycle | 5 | 2021 | 2922 | 0.190 |
Why?
|
| Erythema Chronicum Migrans | 1 | 2021 | 48 | 0.190 |
Why?
|
| Prodrugs | 1 | 2023 | 263 | 0.190 |
Why?
|
| Lipopolysaccharides | 3 | 2020 | 2196 | 0.190 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2023 | 8356 | 0.190 |
Why?
|
| Influenza, Human | 4 | 2021 | 1503 | 0.190 |
Why?
|
| Quantitative Trait Loci | 2 | 2023 | 2028 | 0.190 |
Why?
|
| Antibodies, Neutralizing | 3 | 2021 | 1897 | 0.190 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2021 | 100 | 0.190 |
Why?
|
| Asthma | 1 | 2019 | 6139 | 0.180 |
Why?
|
| Interferons | 4 | 2024 | 701 | 0.180 |
Why?
|
| Female | 41 | 2024 | 382450 | 0.180 |
Why?
|
| Allelic Imbalance | 1 | 2020 | 76 | 0.180 |
Why?
|
| Cryopreservation | 2 | 2023 | 700 | 0.180 |
Why?
|
| Malaria, Vivax | 1 | 2022 | 160 | 0.180 |
Why?
|
| Acute-Phase Reaction | 1 | 2020 | 89 | 0.180 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2021 | 295 | 0.180 |
Why?
|
| PPAR alpha | 1 | 2021 | 176 | 0.170 |
Why?
|
| Anemia, Aplastic | 1 | 2022 | 229 | 0.170 |
Why?
|
| Lactation | 1 | 2022 | 389 | 0.170 |
Why?
|
| Plasma Cells | 2 | 2020 | 589 | 0.170 |
Why?
|
| Cerebral Hemorrhage | 2 | 2021 | 2617 | 0.170 |
Why?
|
| Retinal Neurons | 1 | 2019 | 66 | 0.170 |
Why?
|
| Cell Physiological Phenomena | 1 | 2020 | 151 | 0.170 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2020 | 417 | 0.170 |
Why?
|
| DNA, Complementary | 2 | 2020 | 1994 | 0.170 |
Why?
|
| Serine Endopeptidases | 2 | 2021 | 1014 | 0.170 |
Why?
|
| Phenotype | 7 | 2024 | 16261 | 0.170 |
Why?
|
| Yellow fever virus | 1 | 2018 | 23 | 0.160 |
Why?
|
| Cell Enlargement | 1 | 2018 | 59 | 0.160 |
Why?
|
| Basophils | 1 | 2021 | 406 | 0.160 |
Why?
|
| NIH 3T3 Cells | 1 | 2020 | 674 | 0.160 |
Why?
|
| Toxoplasma | 1 | 2020 | 149 | 0.160 |
Why?
|
| Alkylating Agents | 1 | 2019 | 134 | 0.160 |
Why?
|
| Hepatitis B, Chronic | 1 | 2023 | 400 | 0.160 |
Why?
|
| Yellow Fever Vaccine | 1 | 2018 | 37 | 0.160 |
Why?
|
| Metaplasia | 1 | 2019 | 322 | 0.160 |
Why?
|
| Viruses | 2 | 2013 | 376 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 14 | 2021 | 21600 | 0.160 |
Why?
|
| Male | 35 | 2024 | 351420 | 0.160 |
Why?
|
| Airway Remodeling | 1 | 2019 | 138 | 0.160 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 2210 | 0.160 |
Why?
|
| Biological Assay | 1 | 2021 | 629 | 0.160 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 357 | 0.160 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2018 | 57 | 0.160 |
Why?
|
| Research Report | 1 | 2021 | 359 | 0.150 |
Why?
|
| Career Mobility | 1 | 2020 | 263 | 0.150 |
Why?
|
| Patient Advocacy | 1 | 2020 | 361 | 0.150 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2019 | 179 | 0.150 |
Why?
|
| Systems Integration | 1 | 2020 | 428 | 0.150 |
Why?
|
| Adult | 24 | 2024 | 215192 | 0.150 |
Why?
|
| Human Body | 1 | 2017 | 38 | 0.150 |
Why?
|
| Ecosystem | 1 | 2022 | 475 | 0.150 |
Why?
|
| Th17 Cells | 2 | 2015 | 768 | 0.150 |
Why?
|
| Science | 1 | 2020 | 239 | 0.150 |
Why?
|
| Intestinal Diseases | 1 | 2022 | 507 | 0.150 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2023 | 808 | 0.150 |
Why?
|
| Milk, Human | 1 | 2022 | 474 | 0.150 |
Why?
|
| Asthma, Aspirin-Induced | 1 | 2021 | 203 | 0.150 |
Why?
|
| Colitis, Ulcerative | 2 | 2020 | 1900 | 0.150 |
Why?
|
| Glioblastoma | 3 | 2021 | 3462 | 0.150 |
Why?
|
| Vaccines, Attenuated | 1 | 2018 | 314 | 0.150 |
Why?
|
| Cell Lineage | 3 | 2022 | 2496 | 0.150 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2023 | 1108 | 0.140 |
Why?
|
| Cross-Cultural Comparison | 1 | 2020 | 626 | 0.140 |
Why?
|
| Membranes, Artificial | 1 | 2019 | 370 | 0.140 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 2024 | 807 | 0.140 |
Why?
|
| BCG Vaccine | 1 | 2020 | 365 | 0.140 |
Why?
|
| Stromal Cells | 2 | 2020 | 1301 | 0.140 |
Why?
|
| Immunoglobulin E | 2 | 2020 | 1496 | 0.140 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2021 | 394 | 0.140 |
Why?
|
| Immunomodulation | 1 | 2020 | 541 | 0.140 |
Why?
|
| Embryonic Development | 1 | 2021 | 706 | 0.140 |
Why?
|
| Peanut Hypersensitivity | 1 | 2019 | 212 | 0.140 |
Why?
|
| Congresses as Topic | 1 | 2021 | 790 | 0.140 |
Why?
|
| Retina | 2 | 2019 | 2615 | 0.140 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2017 | 173 | 0.140 |
Why?
|
| Eukaryotic Cells | 1 | 2017 | 195 | 0.140 |
Why?
|
| Ultraviolet Rays | 1 | 2021 | 1058 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2019 | 3578 | 0.140 |
Why?
|
| Cell Proliferation | 6 | 2021 | 10311 | 0.140 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2019 | 547 | 0.140 |
Why?
|
| Eosinophils | 1 | 2021 | 939 | 0.140 |
Why?
|
| Drug Discovery | 2 | 2021 | 1055 | 0.130 |
Why?
|
| Intestinal Mucosa | 3 | 2022 | 2991 | 0.130 |
Why?
|
| Toll-Like Receptors | 3 | 2020 | 586 | 0.130 |
Why?
|
| Sensory Receptor Cells | 1 | 2020 | 496 | 0.130 |
Why?
|
| Genes, X-Linked | 1 | 2016 | 128 | 0.130 |
Why?
|
| Interleukin-13 | 1 | 2018 | 403 | 0.130 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2022 | 1794 | 0.130 |
Why?
|
| Genome | 2 | 2022 | 1744 | 0.130 |
Why?
|
| Forkhead Transcription Factors | 2 | 2021 | 1586 | 0.130 |
Why?
|
| Influenza A virus | 1 | 2019 | 453 | 0.130 |
Why?
|
| Inflammasomes | 1 | 2020 | 519 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2018 | 341 | 0.130 |
Why?
|
| Genetic Heterogeneity | 2 | 2022 | 714 | 0.130 |
Why?
|
| Tumor Escape | 1 | 2018 | 364 | 0.130 |
Why?
|
| Mice, Knockout | 7 | 2021 | 14253 | 0.130 |
Why?
|
| Aorta | 1 | 2023 | 2026 | 0.130 |
Why?
|
| Lymphocyte Activation | 6 | 2024 | 5416 | 0.130 |
Why?
|
| Receptors, CXCR5 | 3 | 2022 | 88 | 0.130 |
Why?
|
| Myeloproliferative Disorders | 1 | 2022 | 616 | 0.130 |
Why?
|
| Base Sequence | 4 | 2019 | 12456 | 0.130 |
Why?
|
| 3T3 Cells | 1 | 2017 | 1084 | 0.130 |
Why?
|
| Hyperplasia | 1 | 2018 | 1154 | 0.120 |
Why?
|
| Endothelial Cells | 3 | 2023 | 3486 | 0.120 |
Why?
|
| Skin Neoplasms | 3 | 2022 | 5685 | 0.120 |
Why?
|
| Immunotherapy | 5 | 2023 | 4593 | 0.120 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2022 | 3541 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2018 | 556 | 0.120 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2024 | 1393 | 0.120 |
Why?
|
| Astrocytoma | 1 | 2019 | 776 | 0.120 |
Why?
|
| Colon | 2 | 2020 | 1770 | 0.120 |
Why?
|
| Aged | 16 | 2024 | 164383 | 0.120 |
Why?
|
| Middle Aged | 19 | 2024 | 214618 | 0.120 |
Why?
|
| Melanoma | 3 | 2018 | 5574 | 0.120 |
Why?
|
| Flow Cytometry | 3 | 2021 | 5843 | 0.120 |
Why?
|
| Antigens, Viral | 2 | 2019 | 984 | 0.120 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2020 | 2585 | 0.120 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2019 | 607 | 0.120 |
Why?
|
| Adaptation, Physiological | 1 | 2021 | 1283 | 0.120 |
Why?
|
| Epigenesis, Genetic | 3 | 2018 | 3654 | 0.120 |
Why?
|
| Lymph Nodes | 3 | 2020 | 3449 | 0.120 |
Why?
|
| Cell Line | 4 | 2020 | 15642 | 0.120 |
Why?
|
| Antigens, Neoplasm | 1 | 2022 | 1975 | 0.120 |
Why?
|
| Career Choice | 1 | 2020 | 743 | 0.120 |
Why?
|
| Haplotypes | 1 | 2020 | 2722 | 0.120 |
Why?
|
| Neuroglia | 1 | 2019 | 937 | 0.110 |
Why?
|
| Retinal Vessels | 1 | 2019 | 823 | 0.110 |
Why?
|
| Anti-Retroviral Agents | 2 | 2020 | 1755 | 0.110 |
Why?
|
| STAT2 Transcription Factor | 1 | 2013 | 27 | 0.110 |
Why?
|
| beta Catenin | 2 | 2020 | 1037 | 0.110 |
Why?
|
| Fluorescent Dyes | 1 | 2021 | 1893 | 0.110 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2013 | 36 | 0.110 |
Why?
|
| Cyclophosphamide | 1 | 2019 | 2200 | 0.110 |
Why?
|
| Fatty Acids | 1 | 2021 | 1777 | 0.110 |
Why?
|
| Salmonella typhimurium | 1 | 2015 | 340 | 0.110 |
Why?
|
| Interleukin-10 | 1 | 2018 | 1162 | 0.110 |
Why?
|
| Peptides | 2 | 2022 | 4321 | 0.110 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 1516 | 0.110 |
Why?
|
| Neoplasm Metastasis | 3 | 2021 | 4823 | 0.110 |
Why?
|
| Leukocytes | 1 | 2021 | 2013 | 0.110 |
Why?
|
| Ovulation | 2 | 2023 | 180 | 0.100 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 1758 | 0.100 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2012 | 83 | 0.100 |
Why?
|
| Lymphoma, B-Cell | 1 | 2019 | 925 | 0.100 |
Why?
|
| Interferon-beta | 1 | 2014 | 331 | 0.100 |
Why?
|
| Malaria | 1 | 2022 | 1202 | 0.100 |
Why?
|
| Young Adult | 9 | 2021 | 57163 | 0.100 |
Why?
|
| Neoplasms | 4 | 2023 | 21715 | 0.100 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 865 | 0.100 |
Why?
|
| Influenza Vaccines | 1 | 2019 | 745 | 0.100 |
Why?
|
| Macular Degeneration | 1 | 2019 | 996 | 0.100 |
Why?
|
| Disease | 1 | 2017 | 660 | 0.100 |
Why?
|
| Antibodies, Viral | 2 | 2021 | 3074 | 0.100 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2020 | 1896 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 1858 | 0.100 |
Why?
|
| Proteomics | 2 | 2022 | 3709 | 0.100 |
Why?
|
| Signal Transduction | 8 | 2023 | 23154 | 0.100 |
Why?
|
| Neoplasm Proteins | 2 | 2022 | 3611 | 0.100 |
Why?
|
| Disease Models, Animal | 8 | 2022 | 17869 | 0.100 |
Why?
|
| Enzymes | 1 | 2012 | 261 | 0.100 |
Why?
|
| Mice, Transgenic | 5 | 2021 | 9513 | 0.100 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 934 | 0.090 |
Why?
|
| Palatine Tonsil | 2 | 2022 | 188 | 0.090 |
Why?
|
| Adolescent | 9 | 2022 | 86278 | 0.090 |
Why?
|
| Alleles | 1 | 2022 | 6837 | 0.090 |
Why?
|
| Equipment Design | 1 | 2019 | 3510 | 0.090 |
Why?
|
| Genetic Variation | 3 | 2015 | 6454 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2020 | 2803 | 0.090 |
Why?
|
| Interleukin-5 | 2 | 2021 | 259 | 0.090 |
Why?
|
| Bone Marrow Cells | 2 | 2019 | 2414 | 0.090 |
Why?
|
| Nasopharynx | 2 | 2024 | 389 | 0.090 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2015 | 811 | 0.090 |
Why?
|
| Disease Management | 1 | 2020 | 2456 | 0.090 |
Why?
|
| Anti-HIV Agents | 2 | 2023 | 4413 | 0.090 |
Why?
|
| Macaca | 2 | 2023 | 407 | 0.090 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2019 | 2029 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2019 | 6068 | 0.080 |
Why?
|
| Patch-Clamp Techniques | 1 | 2012 | 937 | 0.080 |
Why?
|